EP2988750
Notkun landíólólhýdróklóríðs við langtímameðferðina á hraðsláttarglöpum
Status:
EP einkaleyfi: Endurútgefin þýðing EP einkaleyfisEP appl. date:
25.4.2014EP published:
19.1.2022EP application number:
14720107.3
EP translation filed:
24.2.2022Grant published:
15.3.2022EPO information:
European Patent Register
Max expiry date:
24.4.2034Expiry date:
24.4.2026Next due date:
30.4.2026
Title in English:
USE OF LANDIOLOL HYDROCHLORIDE IN THE LONG-TERM TREATMENT OF TACHYARRHYTHMIASLanguage of the patent:
English
Timeline
Today
25.4.2014EP application
19.1.2022EP Publication
24.2.2022Translation submitted
15.3.2022Registration published
24.4.2026Expires
Owner
Name:
AOP Orphan Pharmaceuticals GmbHAddress:
Leopold-Ungar-Platz 2, 1190 Vienna, AT
Inventor
Name:
KRUMPL, GüntherAddress:
1010 Vienna, AT
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
13165582Date:
26.4.2013Country:
EP
Classification
Categories:
A61K 31/5377, A61P 9/06
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 12.4.2022
Expires: 24.4.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 10
Paid: 4.4.2023
Expires: 24.4.2024
Payer: ABP PATENT NETWORK GmbH
Number: 11
Paid: 14.3.2024
Expires: 24.4.2025
Payer: ABP PATENT NETWORK GmbH
Number: 12
Paid: 21.3.2025
Expires: 24.4.2026
Payer: ABP PATENT NETWORK GmbH